Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. (AVIR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AVIR · as of Jun 8, 2026
Key Statistics
Explore Atea Pharmaceuticals, Inc. Data
avir stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 25.0%
The AVIR analyst consensus is Hold, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +130.95% upside from the current price of $4.33.
Competitors & Peers
avir competitorsAVIR
ACHV
ALLO
ARCT
ENTA
HUMAStock Performance
Full HistoryAbout Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its…
what is atea pharmaceuticals, inc. · avir stock overview · atea pharmaceuticals, inc. company profile · who is atea pharmaceuticals, inc. ceo · avir NASDAQ · atea pharmaceuticals, inc. headquarters · atea pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Atea Pharmaceuticals, Inc. (AVIR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 30, 2020. As of the latest trading session, AVIR stock price is $4.33, with a market capitalization of $346.5M. The stock has returned +35.20% over the past 12 months and +21.57% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Atea Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $10.00. In fiscal year 2025, Atea Pharmaceuticals, Inc. reported revenue of — and net income of -$158.3M. For detailed data — including Atea Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Atea Pharmaceuticals, Inc. (AVIR) stock price is $4.33. The stock is traded on NASDAQ under the ticker symbol AVIR. The 52-week range is $2.78 – $6.45.